Issue 23, 2011

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

Abstract

Generator-derived radionuclides for PET/CT imaging are promising for optimizing targeted radiotherapy by an individual patient-based approach, applying pre-therapeutic evaluation, as well as dosimetric calculations, and for measuring treatment response after radionuclide therapy.

Graphical abstract: Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

Article information

Article type
Perspective
Submitted
01 Nov 2010
Accepted
22 Feb 2011
First published
29 Mar 2011

Dalton Trans., 2011,40, 6104-6111

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

F. Rösch and R. P. Baum, Dalton Trans., 2011, 40, 6104 DOI: 10.1039/C0DT01504K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements